Long-Term Outcomes of Neoadjuvant Intraarterial Chemotherapy for Locally Invasive Lacrimal Gland Carcinoma ex Pleomorphic Adenoma
Neoadjuvant IACC with multimodal therapies can achieve favorable outcomes with locoregional control and improve disease-specific survival in patients with locally invasive advanced-stage CXPA of the lacrimal gland.
Authors
- Scott A. McLean (ORCID: https://orcid.org/0000-0002-1884-6632)
- Francis P. Worden (ORCID: https://orcid.org/0000-0002-6632-4951)
- Lena Juratli (ORCID: https://orcid.org/0000-0003-4118-091X)
- Hakan Demirci (ORCID: https://orcid.org/0000-0003-1593-1476)
- Rubina Chaudhary (ORCID: https://orcid.org/0000-0002-0486-1022)
- Victor Maurice Elner (ORCID: https://orcid.org/0000-0001-7708-1898)
- Sarinee Juntipwong
- Jane Kim (ORCID: https://orcid.org/0000-0003-1408-5984)
Institutions
- Kellogg's (Canada) (CA)
- Michigan Medicine (US)
- Eye Center (SA)
Publication Details
- Journal
- Ophthalmic Plastic and Reconstructive Surgery
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1097/iop.0000000000002881
- Citations
- 3
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.72